Citations

Showing 10 of 108162 citations.

Contemporary Surgical Management of Juvenile Nasopharyngeal Angiofibroma
Cohen-Cohen, Salomón , Scheitler, Kristen M. , Janus, Jeffrey R. , Moore, Eric J. , Kasperbauer, Jan L. , Cloft, Harry J. , Link, Michael J., Gompel, Jamie J. Van , Janus, Jeffrey, Van Gompel, Jamie J , Choby, Garret

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 3, 2021 | Volume: 83 | Issue: S 02 | Pages: e266-e273

10.1055/s-0041-1725031 | PMID 35832970 Get It

Abstract Objectives Juvenile nasopharyngeal angiofibromas (JNAs) are uncommon tumors with an evolving treatment paradigm. The objective of this study was to compare our prior experience reported in 2005 with our most contemporary series to compare practice improvements and the impact of expanded endonasal procedures. Design Retrospective review comparing a contemporary 22 patients with JNA who underwent surgical management between 2005 and 2019, compared with a historical cohort of 65 patients from the same center. Results The most common presenting symptom was epistaxis (68%). The median maximum tumor diameter was 4.4 cm. All patients underwent preoperative embolization. An endoscopic endonasal approach (EEA) was used in 18 patients (82%), compared with 9% in the series prior to 2005. Gross total resection was achieved in all patients. The median estimated blood loss was 175 and 350 mL for EEA and open (transfacial) cases, respectively. Only two patients (9%) required a blood transfusion compared with 52% on the previous series. The median follow-up was 19 months. The overall recurrence rate was 9% in this series and 24% in the previous series. No patient required radiation therapy in follow-up compared with 3% in our historical cohort. Conclusion There have been significant changes regarding the management of patients with JNA compared with the previous Mayo Clinic experience. The EEA has become the preferred route over the transfacial approaches to treat JNA in selected patients who do not have intracranial extension. Preoperative embolization has aided in reducing the postoperative transfusion rates.
Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma
DeFino, Catherine E. , Barreto, Jason N. , Pawlenty, Amanda G. , Ruff, Michael W. , Carabenciov, Ivan D. , Mara, Kristin C. , Thompson, Carrie A. , Martin, Catherine E. , Sierzchulski, Amanda G. , Mara, Kristin C

Mayo Clinic

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | March 2, 2021 | Volume: 41 | Issue: 5 | Pages: 430-439

10.1002/phar.2516 | PMID 33655525 Get It

Abstract Study Objective To determine whether there is a drug‐drug interaction precluding the concomitant use of levetiracetam and high‐dose methotrexate (HDMTX). Design Retrospective analysis. Setting Large academic tertiary care medical center. Patients Adult lymphoma patients who received HDMTX as a 4‐h infusion with or without concomitant levetiracetam. Measurements and Main Results Generalized estimating equations clustered on patient were used to assess each outcome. The primary outcome was the incidence of delayed MTX elimination (MTX level >1 µmol/L at 48 h). Secondary outcomes included incidence of acute kidney injury (AKI) and hospital length of stay (LOS). The 430 included patients receiving 1993 doses of HDMTX had a median (IQR) age of 66 (57.5, 72.6) years, 88 (20.5%) received concomitant levetiracetam with at least one dose of MTX, 267 (62.1%) were male, and 397 (92.3%) were Caucasian. HDMTX doses ranged from 1 to 8 g/m 2 . The most common lymphoma diagnoses were systemic diffuse large B‐cell lymphoma (DLBCL; 58.5%) and systemic DLBCL with central nervous system (CNS) involvement (32.8%). Rates of delayed elimination with and without levetiracetam were 13.4% and 16.3%, respectively (OR = 0.80, 95% CI 0.47–1.34, p = 0.39). AKI occurred in 15.6% and 17.0% of patients with and without concomitant levetiracetam, respectively (OR = 0.83, 95% CI 0.52–1.33, p = 0.28). The median LOS with and without levetiracetam was 4.2 and 4.1 days, respectively ( p = 0.039). On multivariable analyses, only age, body surface area, diagnosis of systemic DLBCL with CNS involvement, serum creatinine, hemoglobin, total bilirubin, and dose of HDMTX were associated with delayed elimination. Conclusions High‐dose methotrexate administered with concomitant levetiracetam was not associated with increased risk for delayed MTX elimination or AKI. These results support that levetiracetam and HDMTX are safe for coadministration.
The Change of Plane of the Supratrochlear and Supraorbital Arteries in the Forehead—An Ultrasound-Based Investigation
Cotofana, Sebastian , Velthuis, Peter J. , Alfertshofer, Michael , Frank, Konstantin , Bertucci, Vince , Beleznay, Kate, Swift, Arthur, Gavril, Diana L., Lachman, Nirusha , Cotofana, Sebastian , Alfertshofer, Michael , Frank, Konstantin , Schelke, Leonie

Mayo Clinic

Aesthetic Surgery Journal | March 2, 2021 | Volume: 41 | Issue: 11 | Pages: NP1589-NP1598

10.1093/asj/sjaa421 | PMID 33652475 Get It

Abstract Background Injecting soft tissue fillers into the deep plane of the forehead carries the risk of injection-related visual compromise due to the specific course of the arterial vasculature. Objectives The aim of this study was to investigate the 2- and 3-dimensional location of the change of plane of the deep branch of the supratrochlear and supraorbital artery, respectively. Methods A total of 50 patients (11 males and 39 females; mean age, 49.76 [13.8] years, mean body mass index, 22.53 [2.6] kg/m2) were investigated with ultrasound imaging. The total thickness and the distance of the arteries from the skin and bone surface were measured with an 18-MHz broadband compact linear array transducer. Results The deep branch of the supraorbital artery changed plane from deep to superficial to the frontalis muscle at a mean distance of 13 mm (range, 7.0-19.0 mm) in males and at 14 mm (range, 4.0-24.0 mm) in females and for the deep branch of the supratrochlear artery at a mean distance of 14 mm in males and females (range, 10.0-19.0 in males, 4.0-27.0 in females) when measured from the superior orbital rim. Conclusions Based on the ultrasound findings in this study, it seems that the supraperiosteal plane of the upper and lower forehead could be targeted during soft tissue filler injections because the deep branches of both the supraorbital and supratrochlear arteries do not travel within this plane. The superficial plane of the lower forehead, however, should be avoided due to the unpredictability and inconsistent presence of the central and paracentral arteries. Level of Evidence: 4
Comment on “A Modern Assessment of Cancer Risk in Adrenal Incidentalomas: Analysis of 2219 Patients” by Kahramangil B et al.
Chortis, Vasileios, Sitch, Alice J., Bancos, Irina, Prete, Alessandro, Taylor, Angela E., Biehl, Michael, Deeks, Jonathan J., Arlt, Wiebke, Arlt, Wiebke , Deeks, Jonathan J , Taylor, Angela E. , Sitch, Alice , Biehl, Michael , Prete, Alessandro , Arlt, Wiebke , Prete, Alessandro , Taylor, Angela E , Sitch, Alice J , Chortis, Vasileios, Bancos, Irina, Taylor, Angela E.

Mayo Clinic

Annals of Surgery | March 2, 2021 | Volume: 274 | Issue: 6 | Pages: e887-e888

10.1097/sla.0000000000004804 | PMID 33914489 Get It

Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization Study
Dimou, Niki , Bouras, Emmanouil , Tsilidis, Konstantinos K. , Martin, Richard M. , Gram, Inger Torhild , Bakker, Marije F. , Brenner, Hermann , Figueiredo, Jane C. , Fortner, Renée T. , Gruber, Stephen B. , Guelpen, Bethany Van , Lindor, Noralane M. , Sánchez, María‐José , Tindle, Hilary A. , Weiderpass, Elisabete , Gunter, Marc J. , Murphy, Neil , Martin, Richard M , Gram, Inger T , Brenner, Hermann , Fortner, Renée T , Gruber, Stephen B , Van Guelpen, Bethany , Hsu, Li , Kaaks, Rudolf , Kweon, Sun-Seog , Severi, Gianluca , Tumino, Rosario , Weiderpass, Elisabete , Gunter, Marc J , Murphy, Neil , Dimou, Niki , Tsilidis, Konstantinos K , Bouras, Emmanouil , Sánchez, Maria-Jose , Yarmolinsky, James , Lewis, Sarah J. , Kaaks, Rudolf , Lin, Yi , Newcomb, Polly A. , Severi, Gianluca , ­Tumino, ­Rosario

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | March 2, 2021 | Volume: 30 | Issue: 5 | Pages: 953-964

10.1158/1055-9965.epi-20-1218 | PMID 33653810 Get It

Abstract Background: Observational evidence has shown that smoking is a risk factor for breast and colorectal cancer. We used Mendelian randomization (MR) to examine causal associations between smoking and risks of breast and colorectal cancer. Methods: Genome-Wide Association Study summary data were used to identify genetic variants associated with lifetime amount of smoking (n = 126 variants) and ever having smoked regularly (n = 112 variants). Using two-sample MR, we examined these variants in relation to incident breast (122,977 cases/105,974 controls) and colorectal cancer (52,775 cases/45,940 controls). Results: In inverse-variance weighted models, a genetic predisposition to higher lifetime amount of smoking was positively associated with breast cancer risk [OR per 1-SD increment: 1.13; 95% confidence interval (CI): 1.00–1.26; P = 0.04]; although heterogeneity was observed. Similar associations were found for estrogen receptor–positive and estrogen receptor–negative tumors. Higher lifetime amount of smoking was positively associated with colorectal cancer (OR per 1-SD increment, 1.21; 95% CI, 1.04–1.40; P = 0.01), colon cancer (OR, 1.31; 95% CI, 1.11–1.55; P < 0.01), and rectal cancer (OR, 1.36; 95% CI, 1.07–1.73; P = 0.01). Ever having smoked regularly was not associated with risks of breast (OR, 1.01; 95% CI, 0.90–1.14; P = 0.85) or colorectal cancer (OR, 0.97; 95% CI, 0.86–1.10; P = 0.68). Conclusions: These findings are consistent with prior observational evidence and support a causal role of higher lifetime smoking amount in the development of breast and colorectal cancer. Impact: The results from this comprehensive MR analysis indicate that lifetime smoking is a causal risk factor for these common malignancies.
Determination of the Particulate Size and Aggregation of Clonidine and Corticosteroids for Epidural Steroid Injection
Gazelka, Halena M.

Mayo Clinic

Pain Physician | March 2, 2021 | Volume: 1;15 | Issue: 1;1 | Pages: 87-93

10.36076/ppj.2012/15/87 Get It

Background: Epidural injection of corticosteroids is a commonly used treatment for radicular pain. However, the benefits are often short lived, and repeated injections are often limited secondary to concerns of side effects from cumulative steroid doses. In addition, rare, catastrophic complications, including brain and spinal cord embolic infarcts have been attributed to particulate steroid injections. A previous study has shown that dexamethasone has less particulate than other corticosteroids, possibly reducing embolic risk. Furthermore, a recent study indicated that clonidine may be useful in the treatment of radicular pain when administered via epidural steroid injection. The combination of corticosteroid and clonidine is an intriguing, yet unstudied, alternative to traditional treatment. Objective: Our study examines whether mixing clonidine and various corticosteroids results in increased particle size or aggregation. Methods: Evaluations under light microscopy for particle size were made of samples of clonidine alone and clonidine mixed with equal parts of 3 corticosteroids solutions: dexamethasone sodium phosphate injection, triamcinolone acetonide injectable suspension, and betamethasone sodium phosphate and betamethasone acetate injectable suspension. Four mL each of clonidine (100 μcg/ mL), clonidine (100 μcg/mL) + dexamethasone sodium phosphate injection (4 mg/mL), clonidine (100 μcg/mL) + triamcinolone acetonide injectable suspension (40 mg/mL), and clonidine (100 μcg/mL) + betamethasone sodium phosphate and betamethasone acetate injectable suspension (6 mg/mL) were examined Their particle sizes were compared to measurements taken when each steroid solution was examined alone. Results: Clonidine was determined to be nonparticulate when examined by light microscopy. Clonidine mixed with equal parts of each of the 3 corticosteroids mentioned above did not result in increased clumping or increased particle size over each of the corticosteroids measured alone. Conclusion: Mixing clonidine with corticosteroids did not increase particulation compared to corticosteroids alone. Combining clonidine and corticosteroids for epidural injection may prove to be a useful treatment for radicular pain. The combination of these is unlikely to result in a solution that is more likely to cause embolic infarcts than the use of corticosteroids alone. Key words: steroid, epidural, clonidine, injection, particulate, aggregation
What we (don’t) know about myocardial injury after COVID-19
Friedrich, Matthias G. , Cooper, Leslie T , Cooper, Leslie T.

Mayo Clinic

European Heart Journal | March 2, 2021 | Volume: 42 | Issue: 19 | Pages: 1879-1882

10.1093/eurheartj/ehab145 | PMID 33713116 Get It

DOCK7 protects against replication stress by promoting RPA stability on chromatin
Gao, Ming , Guo, Guijie , Huang, Jinzhou , Hou, Xiaonan , Ham, Hyoungjun , Kim, Wootae , Tu, Xinyi , Zhou, Qin , Zhang, Chao , Zhu, Qian , Liu, Jiaqi , Xu, Zhijie , Luo, Kuntian, Weroha, S. John , Billadeau, Daniel D. , Yan, Yuanliang, Weroha, John, Kim, Wootae , Xu, Zhijie , Zhao, Fei , Yan, Yuanliang , Yin, Ping , Deng, Min , Lou, Zhenkun , Guo, Guijie

Mayo Clinic

Nucleic Acids Research | March 2, 2021 | Volume: 49 | Issue: 6 | Pages: 3322-3337

10.1093/nar/gkab134 | PMID 33704464 Get It

Abstract RPA is a critical factor for DNA replication and replication stress response. Surprisingly, we found that chromatin RPA stability is tightly regulated. We report that the GDP/GTP exchange factor DOCK7 acts as a critical replication stress regulator to promote RPA stability on chromatin. DOCK7 is phosphorylated by ATR and then recruited by MDC1 to the chromatin and replication fork during replication stress. DOCK7-mediated Rac1/Cdc42 activation leads to the activation of PAK1, which subsequently phosphorylates RPA1 at S135 and T180 to stabilize chromatin-loaded RPA1 and ensure proper replication stress response. Moreover, DOCK7 is overexpressed in ovarian cancer and depleting DOCK7 sensitizes cancer cells to camptothecin. Taken together, our results highlight a novel role for DOCK7 in regulation of the replication stress response and highlight potential therapeutic targets to overcome chemoresistance in cancer.
Lumbosacral Radiculoplexus Neuropathy
Pinto, Marcus Vinícius , Ng, Peng-Soon, Howe, Benjamin M. , Laughlin, Ruple S. , Thapa, Prabin , Dyck, P. James B. , Pinto, Marcus V , Dyck, P James B , Ng, Peng‐Soon

Mayo Clinic

Neurology | March 2, 2021 | Volume: 96 | Issue: 16 | Pages: No page available

10.1212/wnl.0000000000011799 | PMID 33653898 Get It